BIOY vs XLV
5YGraniteShares YieldBOOST Biotech ETF · $2MState Street Health Care Select Sector SPDR ETF · $49.1B
[…]3 years · per year[…] · $15,709+16.2%
[…]5 years · per year[…] · $15,068+8.5%
14.98%Expense ratio$1,498 · $8 on $10k · lower wins0.08%
33.84%12-mo yield$3,384 · $139 on $10k1.39%
[…]Worst dropSmaller wins−10.5%
[…]VolatilityLower wins16.4%
1–1Level
$10,000 · 5 yearsOne scale
Shared top holdingsBIOY · XLV
They share no top holdings, or holdings aren’t on file […]
Held in common[…]
End-of-day Nov 3, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two